Peroxitech

Peroxitech Therapeutics

Peroxitech Therapeutics develops peptide-based treatments for acute lung injury and respiratory distress to serve patients with severe inflammatory conditions.

ChainPeptides

This company develops synthetic antimicrobial peptides to treat chronic wounds and combat multi-drug resistant bacterial infections for healthcare providers and patients.

AsclepiX Therapeutics

This biopharmaceutical firm develops peptide therapeutics for patients with retinal diseases and cancer using a computational biology platform.

NuVox Pharma

This clinical-stage biotechnology company develops oxygen therapeutics to treat hypoxia in patients at comprehensive centres for oncology, stroke and respiratory care.

Parabilis Medicines

This biopharmaceutical company develops helical peptide therapeutics to treat cancer and other serious diseases for patients with previously untreatable medical conditions.

Apini Therapeutics

This biotechnology company develops small molecule compounds to treat chronic inflammatory diseases for healthcare providers and patients.

Avexegen

This biopharmaceutical company develops peptide therapies to treat gastrointestinal disorders and restore gut health for patients with inflammatory conditions.

Transient Pharma AB

This company develops systemic peptide-based drugs for patients with inflammatory conditions, focusing on gastrointestinal disorders and acute infections.